CCEL
Cryo-Cell International Inc.
stockNYSEAMERICAN
founded in 1989, cryo-cell is the oldest cord blood bank and was the first cord blood bank to separate and store stem cells in 1992. today, the company has over 270,000 clients worldwide. since inception, 100% of our clients' specimens have been successfully viable upon thaw. our services include umbilical cord blood, cord tissue and menstrual stem cell banking. cryo-cell operates its own state-of-the-art processing, testing and cryopreservation operation. we are in complete control of every step, ensuring the highest quality available today.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 4.36 | 2026-10-09 | +0.46% | -3.231 |
| 1M | 4.41 | 2026-09-16 | -0.68% | -3.864 |
| 3M | 3.48 | 2026-07-16 | +25.86% | -0.212 |
| 6M | 3.62 | 2026-04-16 | +20.99% | 0.585 |
| 1Y | 4.50 | 2025-10-16 | -2.67% | 0.238 |
| 2Y | 6.25 | 2024-10-16 | -29.92% | — |
| 5Y | 13.15 | 2021-10-15 | -66.69% | 0.009 |
Cryo-Cell International Inc. (NYSEAMERICAN:CCEL) stock price today is $4.38, and today's volume is 9,633. CCEL is up 20.000% today. The 30 day average volume is 15,499. CCEL market cap is $35.31M with 8.06M shares outstanding.